Glimpse Group gets Nasdaq delisting notice
Nasdaq has issued a delisting determination for BTLN over the $1.00 bid-price rule, with listing now dependent on a pending appeal.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Glimpse Group, Inc. (BTLN), through its subsidiary Brightline Interactive, Inc., reports that on September 11, 2026 it received a Nasdaq staff determination to delist its common stock for failure to meet Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of at least $1.00 per share. The bid price had been below $1.00 for 30 consecutive business days, and the company did not regain compliance by the 180‑day grace period ending September 9, 2026. The company plans to timely request a hearing before a Nasdaq Hearings Panel, which would stay suspension and filing of a Form 25‑NSE and keep the stock listed pending a written decision, but there is no assurance that continued listing will be granted.
Positive
- None.
Negative
- Nasdaq delisting determination issued on September 11, 2026 after Brightline Interactive, Inc. failed to regain compliance with the $1.00 minimum bid price requirement within the 180‑day grace period ending September 9, 2026, creating significant uncertainty around BTLN’s continued Nasdaq listing.
- Continued listing on Nasdaq is now subject to a Nasdaq Hearings Panel decision, and the company explicitly notes there is no assurance that the appeal will be granted or that it can meet listing criteria within any additional period.
Filing Explained
The appeal must be requested by 4:00 p.m. Eastern on September 18, 2026; if requested, it keeps the common stock listed and prevents suspension and Form 25-NSE filing while the Nasdaq panel decides.
8-K Event Classification
Key Figures
Key Terms
Nasdaq Listing Rule 5550(a)(2) regulatory
minimum bid price financial
Form 25-NSE regulatory
Nasdaq Hearings Panel regulatory
forward-looking statements regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did Nasdaq issue a delisting determination for BTLN?
What compliance deadline did BTLN miss under Nasdaq’s bid-price rule?
Can BTLN appeal Nasdaq’s delisting determination?
Will BTLN remain listed on Nasdaq during the appeal process?
Does BTLN guarantee it will keep its Nasdaq listing after the hearing?
AI-generated analysis. How Rhea-AI works. Not financial advice.